Cost of Goods Sold: The difference between beginning and ending inventories for tangible products, resulting in an expense that reflects production and sales costs.
AbbVie Inc. (ABBV) had Cost of Goods Sold of $4.55B for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$16.62B |
|
$1.82B |
|
|
Cost of Goods Sold |
$4.55B |
$12.07B |
|
$12.07B |
|
$4.54B |
|
$-1.88B |
|
$2.67B |
|
$2.67B |
|
$1.81B |
|
$1.81B |
|
$1.81B |
|
$1.81B |
|
$4.54B |
|
-- |
|
-- |
|
1.77B |
|
-- |
|
$1.02 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
$0.00M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Cash Flow Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|